Regulation of metabolic pathways in NKT cells
Regulation of metabolic pathways in NKT cells
批准号:
10649509
负责人:
Cheong-Hee Chang
金额:
$47.77万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-07 至 2025-06-30
关键词:
Adipose tissueAdoptedAreaAutoimmune DiseasesBiochemical PathwayBioenergeticsCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCarbonCell Cycle ProgressionCell RespirationCell SurvivalCell physiologyCellsCellular Metabolic ProcessChronicCytotoxic T-LymphocytesDataDevelopmentDiabetes MellitusEctopic ExpressionEnvironmentEnzymesEquilibriumExhibitsExperimental ModelsGene ExpressionGenerationsGlucoseGlutamatesGlutamineGlutathioneGlycolysis InductionGrowthHealth systemHumanHuman CharacteristicsImmune System DiseasesImmune responseInfectionInflammatoryInterferonsKnowledgeLiverMalignant NeoplasmsMeasuresMediatingMemoryMetabolicMetabolic PathwayMetabolismMissionMitochondriaOutcomeOutcome StudyOxidative PhosphorylationPathogenesisPentosephosphate PathwayPhenotypePlayPopulation HeterogeneityProductionProliferatingPublic HealthPublishingReactive Oxygen SpeciesRegulationResearchRestRoleSignal PathwaySignal TransductionSiteSourceStarvationT cell differentiationT-Cell ActivationT-Cell ProliferationT-LymphocyteTestingThymus GlandTimeTissuesUnited States National Institutes of HealthZNF145 geneaerobic glycolysisarmcancer cellcytokinecytotoxicityglucose metabolismglucose uptakeinnovationinsightmacromoleculemetabolomicsprogramsresponsetherapy designvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
In conventional T cells, signaling pathways that control cellular metabolism have a crucial role in dictating the
outcome of T cell activation and their effector function. Resting CD4 and CD8 T cells use predominantly
oxidative metabolism but stimulation leads them to sharply increase glucose metabolism and adopt aerobic
glycolysis as a primary metabolic program. However, little is known about metabolic regulation and its role for
cellular functions of Natural Killer T (NKT) cells although recent studies indicate an important role of
metabolism in NKT cell differentiation. NKT cells are a heterogeneous population that shows a high degree of
phenotypic and functional specialization. When activated, unlike conventional T cells, NKT cells exhibit a fast
and robust effector function such as cytokine release or cytotoxicity. NKT cells can exert either an inflammatory
or a regulatory function depending on the tissue type such as liver or adipose tissue, respectively, that are a
site of metainflammation. Thus, the metabolic regulation in NKT cells likely plays an important role in immune
diseases. To understand how NKT cells regulate their metabolism to mediate an appropriate immune response
under a different environment, we measured parameters that associate with the metabolic capacity and
compared them with that of CD4 T cells. Our study revealed that NKT cells are very different from CD4 T cells
in many ways. NKT cells rely more on oxidative phosphorylation for their survival and repurposed Glc carbon is
used for optimal cytokine expression. In addition, NKT cells rely on glutamine (Gln) metabolism for proliferation
but not to express IFN-. Gln starved NKT cells seem to be inefficient to switch to glucose (Glc) metabolism,
which is similar to Gln-addicted cancer cells. Metabolomic data revealed that NKT cells have elevated
glutamine metabolites prior to stimulation further supporting an essential role of Gln metabolism. mTORC and
AMPK is known to increase and decrease Gln metabolism, respectively. In line with this, NKT cells are
sensitive to mTORC inhibition but AMPK deficiency results in hyperproliferation and increased cytokine
expression. Based on our data, we hypothesize that the proper regulation of Gln metabolism is critical for NKT
cells’ survival and function, which is controlled by the balance between mTORC and AMPK activity. To test the
hypothesis, we propose two specific aims. Aim 1 will investigate the mechanisms by which Gln controls NKT
cell proliferation and function, and Aim 2 will focus on the mTORC-AMPK axis to discern the regulation of Gln
metabolism in NKT cells. Metabolic status and regulation in NKT cells is virtually unexplored and, therefore,
investigating the regulation of the metabolic networks in NKT cells is highly innovative. Undoubtedly, the
proposed studies are significant given the fact that these studies will address a poorly understood area, and
the results will establish specific and selective metabolic demands of NKT cells.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.celrep.2022.111516
发表时间:
2022-10-25
期刊:
CELL REPORTS
影响因子:
8.8
作者:
[Kumar, Ajay, Yarosz, Emily L., Andren, Anthony, Zhang, Li, Lyssiotis, Costas A., Chang, Cheong-Hee]
通讯作者:
Chang, Cheong-Hee
DOI:
10.4049/immunohorizons.2300002
发表时间:
2023-03-01
期刊:
ImmunoHorizons
影响因子:
--
作者:
[Yarosz EL, Kumar A, Singer JD, Chang CH]
通讯作者:
Chang CH
Regulation of metabolic pathways in NKT cells
-
批准号:10431943
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2020
-
负责人:Cheong-Hee Chang
-
依托单位:
Regulation of metabolic pathways in NKT cells
-
批准号:10212213
-
项目类别:
-
资助金额:$54.56万
-
财政年份:2020
-
负责人:Cheong-Hee Chang
-
依托单位:
High throughput analysis of latency/reactivation with barcoded proviruses
-
批准号:9322472
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2016
-
负责人:Cheong-Hee Chang
-
依托单位:
High throughput analysis of latency/reactivation with barcoded proviruses
-
批准号:9291721
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2016
-
负责人:Cheong-Hee Chang
-
依托单位:
Innate T cell metabolism and immune diseases
-
批准号:9193058
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Cheong-Hee Chang
-
依托单位:
High throughput analysis of latency/reactivation with barcoded proviruses
-
批准号:8841930
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2014
-
负责人:Cheong-Hee Chang
-
依托单位:
Mechanisms generating suppressor CD4 T cells by thymocyte-mediated development
-
批准号:8529764
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2012
-
负责人:Cheong-Hee Chang
-
依托单位:
Immune regulation by thymocyte-selected CD4 T cells
-
批准号:8415531
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2009
-
负责人:Cheong-Hee Chang
-
依托单位:
Immune regulation by thymocyte-selected CD4 T cells
-
批准号:7587186
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2009
-
负责人:Cheong-Hee Chang
-
依托单位:
Immune regulation by thymocyte-selected CD4 T cells
-
批准号:7999264
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2009
-
负责人:Cheong-Hee Chang
-
依托单位:
Immune regulation by thymocyte-selected CD4 T cells
-
批准号:8206711
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2009
-
负责人:Cheong-Hee Chang
-
依托单位:
Immune regulation by thymocyte-selected CD4 T cells
-
批准号:7746488
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2009
-
负责人:Cheong-Hee Chang
-
依托单位:
Immune regulation by thymocyte-selected CD4 T cells
-
批准号:7614833
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2008
-
负责人:Cheong-Hee Chang
-
依托单位:
Dendrituc Cell-Mediated Immunity in AD
-
批准号:7150324
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2006
-
负责人:Cheong-Hee Chang
-
依托单位:
Poxvirus Modulation of Immune Responses
-
批准号:6677463
-
项目类别:
-
资助金额:$73.61万
-
财政年份:2003
-
负责人:Cheong-Hee Chang
-
依托单位:
Poxvirus Modulation of Immune Responses
-
批准号:6925766
-
项目类别:
-
资助金额:$2.04万
-
财政年份:2003
-
负责人:Cheong-Hee Chang
-
依托单位:
Poxvirus Modulation of Immune Responses
-
批准号:6795049
-
项目类别:
-
资助金额:$147.47万
-
财政年份:2003
-
负责人:Cheong-Hee Chang
-
依托单位:
Poxvirus Modulation of Immune Responses
-
批准号:6856524
-
项目类别:
-
资助金额:$155.28万
-
财政年份:2003
-
负责人:Cheong-Hee Chang
-
依托单位:
MHC Class II Transactivator Function & Regulation
-
批准号:6887829
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2002
-
负责人:Cheong-Hee Chang
-
依托单位:
MHC Class II Transactivator Function & Regulation
-
批准号:6726130
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2002
-
负责人:Cheong-Hee Chang
-
依托单位:
海外基金